Advertisement

Y-mAbs Therapeutics, Inc. YMAB

Set alert

Price alert · YMAB

All alert types
8.61 0.00 0.00%

At close · Sep 16

8.61 Day range 8.61
6.48 52-week range 20.90
Open
8.61
Prev close
8.61
Mkt cap
363.24M
Vol
760.67K
Avg vol
249.12K
EPS
-0.54
P/E
0.00
Div yield
0.00%
More statistics
Low
8.61
High
8.61
Forward P/E
-13.98
Beta
0.67
Short ratio
13.91
Inst. own
72.19%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
12.41
200-d avg
13.15
1y target
20.64

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for YMAB has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Other Income → Expenses: $2.32MExpenses → Selling, General & Admin: $11.31MExpenses → Research & Development: $11.10MExpenses → Income Tax: $7.00KProduct → Revenue: $19.02MGross Profit → Expenses: $16.86MRevenue → Gross Profit: $16.86MRevenue → Cost of Revenue: $2.66MNet Loss → Expenses: $3.24MLicense → Revenue: $500.00KOther Income$2.32MGross Profit$16.86MNet Loss$3.24MCost of Revenue$2.66MExpenses$22.42MSelling, General & Admin$11.31MResearch & Development$11.10MIncome Tax$7.00KRevenue$19.52MProduct$19.02MLicense$500.00K

Period ending Jun 30, 2025 · select a line to chart its history

Income statement

YMAB quarterly income statement
19.52M
19.52M
2.71M
16.81M
22.42M
11.10M
11.31M
-5.60M
-2.37M
7.00K
-3.24M
-3.24M
-3.24M
-3.24M
-0.07
-0.07
-0.07
-5.60M
-5.60M
45.32M
45.32M

Balance sheet

YMAB quarterly balance sheet
62.29M
62.29M
15.74M
91.79M
3.38M
117.21M
486.00K
3.12M
22.95M
2.64M
29.72M
-495.57M
-612.00K
87.49M
87.49M
25.42M
3.12M
2.18M
28.94M
6.77M
7.57M

Cash flow

YMAB quarterly cash flow
53.00K
332.00K
1.98M
332.00K
1.65M
2.90M
Advertisement